Prevalence of human papillomavirus infection among women in Concordia, Argentina: A population-based study

Sexually Transmitted Diseases

Volumn 30, Issue 8, 2003, Pages 593-599

  Matos, Elena ^a   Loria, Dora ^a   Amestoy, Gustavo M ^b   Herrera, Lily ^c   Prince, Miguel A ^c   Moreno, Juan ^c   Krunfly, Cristina ^c   Van Den Brule, A J C ^d   Meijer, Chris J L M ^d   Muñoz, Nubia ^e,f   Herrero, Rolando ^e,f   Converti, N ^g   Fainman, E ^g   Garcia, G ^g   Joannas, S ^g   Kobal, A ^g   Lasco, M S ^g   Ledo, P ^g   Mas, A ^g   Oppel, E ^g   Ragone, M A ^g   Rios, H ^g   Ripoll, M A ^g   Rivas, F ^g   Rivas, J ^g   Rivero, G ^g   Rodriquez, G ^g   Scattone, C ^g   Tolomei, R ^g   Rodriguez, A M ^g   Taborda, M F ^g   Lorenzo, Y ^g   Barrios, L ^g   Pellandino, M ^g   Quiroz, C ^g   Vilensky, M ^g   more..

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

^c Hospital Felipe Heras   (Argentina)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f Proyecto Epidemiologico Guanacaste   (Costa Rica)

^g Costa Rican Found for Hlth Sci ^*

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; COLPOSCOPY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; FEMALE GENITAL TRACT INFECTION; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VAGINA DISCHARGE; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; ARGENTINA; COLPOSCOPY; DNA, VIRAL; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; QUESTIONNAIRES; SEXUAL BEHAVIOR; URBAN POPULATION; VAGINAL SMEARS;

EID: 10744229691     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000085181.25063.6C     Document Type: Article

References (27)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in five Continents. Vol 2. Lyon, France: International Agency for Research on Cancer, 1997.
2. Beral V, Hermon C, Muñoz N, Devesa S. Cervical cancer. Cancer Surveys 1994; 19/20:265-285.
3. Matos E, Loria D, Vilensky M, García C. Cancer Mortality Atlas: Argentina 1989-1992. Buenos Aires: Comité Argentino de Coordinación, Programa Latinoamérica contra el Cáncer, 1997.
4. Matos E, Loria D, Vilensky M. Cancer mortality and poverty in Argentina: a geographic correlation study. Cancer Epidemiology Biomarkers and Prevention 1994; 3:213-218.
5. Human Papillomaviruses (IARC Monogr Eval Carcinog Risks Hum 64). Lyon, France: International Agency for Research on Cancer, 1995.
6. Muñoz N, Bosch FX, Shah KV, Meheus A, eds. The Epidemiology of Cervical Cancer and Human Papillomavirus, Lyon, France: International Agency for Research on Cancer, 1995.
7. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92:464-474.
8. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV. J Pathol 1999; 189:12-19.
9. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 1999; 354:20-25.
10. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180:1415-1423.
11. Lowy DR, Schiller JT. Papillomaviruses and cervical cancer: pathogenesis and vaccine development. J Natl Cancer Inst Monographs 1998; 23:27-30.
12. Lazcano-Ponce EC, Miquel JF, Muñoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. Cancer 2001; 51:349-364.
13. Prince MA, Loria D, Herrera L, Matos E. Argentina: Concordia. In: Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents. Vol. 2. Lyon, France: International Agency for Research on Cancer, 1997; 1997:94-97.
14. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35:791-795.
15. Jacobs MV, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM, Walboomers JWW. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PC and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33:901-905.
16. Jacobs MV, Walboomers JM, Snijder PJ, et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000; 87:221-227.
17. Walboomers JWW, Melkert P, van den Brule AJ Snijders PJF, Meijer CJLM. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. In: Herrington CS, McGee O, eds. Diagnostic molecular pathology: a practical approach. Oxford: University Press Oxford, 1992:152-172.
18. Stata Corporation. Stata Statistical Software: Release 5.0. College Station, Texas: Stata Corporation, 1997.
19. Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001; 10:101-106.
20. Watts DH, Koutsky LA, Holmes KK, et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Epidemiol 1998; 178:365-373.
21. Dillner J, Andersson-Ellstrom A, Hagmar B, Schiller J. High risk genital papillomavirus infections are not spread vertically. Rev Med Virol 1999; 9:23-29.
22. Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to dessication. J Infect Dis 1997; 176:1076-1079.
23. Melkert PW, Hopman E, van den Brule AJ, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993; 53:919-923.
24. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervico-vaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996; 23:333-341.
25. Castellsagué X, Menéndez C, Loscertales MP, et al. Human papillomavirus genotypes in rural Mozambique. Lancet 2001; 358:1429-1430.
26. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001:1-8.
27. Deacon JM, Evans CD, Yule R, et al. Sexual bahaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000; 83:1565-1572.